![Quantitative SERS Detection of Uric Acid via Formation of Precise Plasmonic Nanojunctions within Aggregates of Gold Nanoparticles and Cucurbit[n]uril](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F61682.jpg&w=3840&q=50)
Hypouricemia and Urate Transporters
Naoyuki Otani1, Motoshi Ouchi2, Kazuharu Misawa3
1Department of Clinical Pharmacology and Therapeutics, Faculty of Medicine, Oita University, Yufu 879-5593, Oita, Japan.
Biomedicines
|March 25, 2022
Summary
Renal hypouricemia (RHUC) is a rare disorder causing low serum uric acid. This condition, common in Japan due to URAT1 deficiency, increases risks for kidney injury and stones.
Area of Science:
- Nephrology
- Genetics
- Biochemistry
Background:
- Hypouricemia, a rare disorder with serum uric acid ≤ 2.0 mg/dL, is classified into overexcretion and underproduction types.
- Renal hypouricemia (RHUC) represents the underproduction type, often linked to genetic factors.
- In Japan, RHUC resulting from URAT1 deficiency is frequent, causing most persistent, asymptomatic hypouricemia cases.
Purpose of the Study:
- To highlight the prevalence and clinical significance of renal hypouricemia (RHUC).
- To emphasize the association between RHUC and increased risks of exercise-induced acute kidney injury and urolithiasis.
- To advocate for increased research into RHUC pathophysiology and potential therapeutic strategies.
Main Methods:
- Literature review and analysis of existing data on hypouricemia and renal hypouricemia.
- Focus on the genetic basis of RHUC, particularly URAT1 deficiency.
- Clinical case analysis and risk assessment for associated renal complications.
Main Results:
- Renal hypouricemia (RHUC) is a significant cause of persistent hypouricemia, especially in Japan due to URAT1 deficiency.
- Patients with RHUC face elevated risks for exercise-induced acute kidney injury and kidney stone formation.
- The study underscores the importance of identifying and managing RHUC.
Conclusions:
- Renal hypouricemia (RHUC) is a clinically relevant condition with significant renal risks.
- Further research into RHUC pathophysiology is crucial for developing effective treatments.
- Understanding RHUC may offer insights into novel therapeutic approaches for gout and hyperuricemia.
Related Concept Videos
01:15Drug Elimination by Renal Route: Tubular Secretion
2.8K
Once the process of glomerular filtration is completed, blood carrying unfiltered drug molecules traverses through efferent arterioles and makes its way into the peritubular capillaries in the proximal tubule. A variety of carriers play a pivotal role in actively secreting drugs from these peritubular capillaries into the tubular fluid. The organic anion transporter transfers acidic drugs, against an electrochemical gradient, from the peritubular capillaries into the renal tubule cells and...
2.8K
01:14Hepatic Drug Clearance: Role of Transporters
126
In the liver and bile canaliculi, influx and efflux transporters modification can influence intrinsic clearance. Transporters play a significant role in moving drugs within liver cells. Elaborate models, such as the Biopharmaceutical Classification System (BCS), are essential to relate transporters to drug disposition. This system categorizes drugs into four classes based on solubility and permeability, providing insights into elimination routes and the effects of transporters following oral...
126
01:28Renal Drug Excretion: Tubular Secretion
395
Active tubular secretion is a robust, energy-demanding process that utilizes carrier systems to transport drugs into renal tubules. The active renal secretion systems include the organic anion transporter (OAT) for weak acids and the organic cation transporter (OCT) for weak bases. Structurally similar drugs can compete for the same transporter, potentially leading to drug accumulation and toxicity. However, this principle can be exploited therapeutically. One example is probenecid (Probalan),...
395
01:17Pore Transport and Ion-Pair Transport
708
Pore transport and ion-pair formation are critical mechanisms for the absorption and distribution of drugs in the body.
Pore transport, also known as convective transport, is a process where small molecules like urea, water, and sugars rapidly cross cell membranes as though there were channels or pores in the membrane. Although direct microscopic evidence is limited but the concept of pores or channels is widely accepted based on physiological evidence. Despite the lack of direct...
Pore transport, also known as convective transport, is a process where small molecules like urea, water, and sugars rapidly cross cell membranes as though there were channels or pores in the membrane. Although direct microscopic evidence is limited but the concept of pores or channels is widely accepted based on physiological evidence. Despite the lack of direct...
708
01:06Carrier-Mediated Transport
575
Carrier-mediated transport is a pivotal process in drug absorption, particularly for lipid-insoluble drugs, and encompasses facilitated diffusion and active transport. Facilitated diffusion allows drugs to move along their concentration gradient without energy expenditure, while active transport utilizes ATP to drive drug movement against this gradient.
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
575
01:27Glucose Transporters
25.2K
Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
25.2K